Article

MUSC's Storm Eye Institue's newly appointed endowed chairs

Charleston, SC-Three endowed chairs have been appointed at the Medical University of South Carolina's (MUSC) Storm Eye Institute. Craig E. Crosson, PhD, Gene R. Howard, MD, MPH, and Kerry D. Solomon, MD, will serve as chairs in the ophthalmology department.

Charleston, SC-Three endowed chairs have been appointed at the Medical University of South Carolina's (MUSC) Storm Eye Institute. Craig E. Crosson, PhD, Gene R. Howard, MD, MPH, and Kerry D. Solomon, MD, will serve as chairs in the ophthalmology department.

Dr. Solomon has been a professor of ophthalmology and member of the MUSC's faculty since 1993. He has been appointed to the Arturo and Holly Melosi Chair in Ophthalmology. He is the medical director of the Magill Vision Center, director of the Magill Research Center, and director of the Cornea Service at the Storm Eye Institute.

He went to the University of Vermont School of Medicine to obtain his medical degree and did his medical internship at Yale University; he did a fellowship at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, for specialty training in advanced surgical techniques for cataract and refractive surgery and corneal transplantations.

Dr. Crosson is a leader in glaucoma research and serves as vice chairman for research at the Storm Eye Institute. He has been appointed to the Pawek-Vallotton Chair in Ophthalmology. Storm Eye Institute was able to reach Top Ten status nationally as a research institution under his leadership.

He obtained his PhD from Colorado State University and completed his post-doctoral work at the Louisiana State University eye center, New Orleans. He is currently editor-in-chief of the Journal of Ocular Pharmacology Therapeutics.

The Stanley H. and Theodora L. Feldberg Chair, Dr. Howard is also a professor of ophthalmology and attending physician at MUSC and serves as consulting staff to the MUSC Hollings Cancer Center.

Dr. Howard completed his master's degree in public health, his MD, internship in internal medicine and research fellowship at Johns Hopkins University School of Medicine. He also completed a fellowship in ophthalmic plastic and reconstructive surgery and orbital oncology at the University of Iowa in Iowa City and completed his residency at the University of Illinois, Chicago. He currently serves as a delegate to the South Medical Association and is a past-president of the Charleston Ophthalmological Society.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.